Open AccessCYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel
Author(s) -
Daniel L. Hertz,
Alison A. MotsingerReif,
Amy Drobish,
Stacey J. Winham,
Howard L. McLeod,
Lisa A. Carey,
E. Claire Dees
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/cyk5-ch98
Subject(s) - paclitaxel , breast cancer , oncology , medicine , neoadjuvant therapy , cancer